Micro Emerging Active

Desenvolvimento OV329 da Ovid Therapeutics

Pontuação
0,2
Velocidade
▲ 0,0
Artigos
1
Fontes
1

Resumo

An article belongs to this narrative if it covers Ovid Therapeutics' OV329 drug candidate, its potential advantages over existing treatments, and the company's funding efforts.

Artigos Relacionados

Here's Why Ovid Therapeutics Stock Popped Higher Today

Nasdaq · Mar 18, 2026

Fontes

Here's Why Ovid Therapeutics Stock Popped Higher Today Nasdaq

Cronologia

Última atualização Mar 18, 2026